Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S1.12
P/E—
Fwd P/E13.99
PEG0.73
52W— – —
RSI—
Target$208.57 (-13.4%)
Beta0.88
Div—
Loading chart…
RSI (14)
Loading patterns…
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 69
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
4Bullish
1Bearish
0Neutral
▲ Double Bottom — Two lows ~$145.53 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$189.09 — bullish reversal confirmed
▲ Bull Flag — Breakout after +11% pole — bullish continuation
▲ Bull Flag — Breakout after +20% pole — bullish continuation
▼ Double Top — Two peaks ~$202.62 — bearish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
50%
4/8 quarters
Wall Street Consensus
HOLD
BuyHoldSell
Price Target Range
$208.57
-13.4% upside
Low $145
—
High $270
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | — | ↔ Maintain | 2026-07-14 |
| UBS | Buy | — | ↔ Maintain | 2026-07-10 |
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-07-09 |
| TD Cowen | Hold | — | ↔ Maintain | 2026-05-11 |
| Deutsche Bank | Buy | Hold → Buy | ▲ Upgrade | 2026-05-06 |
Truist Securities
2026-07-14
Hold
↔ Maintain
UBS
2026-07-10
Buy
↔ Maintain
Barclays
2026-07-09
Equal-Weight
↔ Maintain
TD Cowen
2026-05-11
Hold
↔ Maintain
Deutsche Bank
2026-05-06
Buy
(from Hold)
▲ Upgrade
Profitability
Gross Margin
32.45%TTM
Op. Margin
13.86%TTM
ROE
80.98%TTM
Rev. Growth
6.00%YoY
Free Cash Flow
999.66MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
1261.33MRQ
Current Ratio
1.42MRQ
Cash
666.55MMRQ
Total Debt
13.22BMRQ
Net Debt
—MRQ
How DVA Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 15.47B |
| Enterprise Value | 29.83B |
| Trailing P/E | 23.24 |
| Forward P/E | 13.99 |
| PEG Ratio (5yr) | 0.73 |
| Price/Sales (ttm) | 1.12 |
| Price/Book (mrq) | -21.11 |
| EV/Revenue | 2.16 |
| EV/EBITDA | 10.68 |
Share Statistics
| Avg Vol (3m) | 876.27K |
| Shares Outstanding | 64.19M |
| Float | 34.17M |
| % Held by Insiders | 46.90% |
| % Held by Institutions | 52.97% |
| Short Ratio | 5.27 |
| Short % of Float | 13.70% |
Profitability
| Gross Margin | 32.45% |
| Operating Margin (ttm) | 13.86% |
| Profit Margin | 5.65% |
| Return on Assets (ttm) | 7.50% |
| Return on Equity (ttm) | 80.98% |
Income Statement
| Revenue (ttm) | 13.84B |
| Revenue Growth (yoy) | 6.00% |
| Gross Profit (ttm) | 4.49B |
| EBITDA | 2.79B |
| Net Income (ttm) | 756.42M |
| Diluted EPS (ttm) | 10.37 |
| EPS Growth (yoy) | 43.50% |
Balance Sheet
| Total Cash (mrq) | 666.55M |
| Total Debt (mrq) | 13.22B |
| Debt / Equity (mrq) | 1261.33 |
| Current Ratio (mrq) | 1.42 |
| Book Value / Share | -11.41 |
| Operating CF (ttm) | 2.03B |
| Free Cash Flow (ttm) | 999.66M |
Trading & Dividends
| Beta (5Y) | 0.88 |
| 50-Day MA | 214.34 |
| 200-Day MA | 154.92 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 52.97%
Insider 46.90%
Public 0.1%
Short Interest
13.70% of float
High
Institutional 13F Holdings
Famous investors who disclosed a position in DVA in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | RODRIGUEZ JAVIER J | Chief Executive Officer | Sale at price 209.28 - 209.50 per share. | 69,407 | $14,532,108 |
| 2026-06-15 | WATERS KATHLEEN ALYCE | Officer | Sale at price 207.84 - 209.17 per share. | 15,405 | $3,210,377 |
| 2026-05-26 | YALE PHYLLIS R | Director | Stock Gift at price 0.00 per share. | 5,038 | — |
| 2026-05-15 | ARWAY PAMELA M. | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | PULLIN DENNIS W | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | SCHOPPERT WENDY LEE | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | MOORE GREGORY J | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | HOLLAR JASON M | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | DESOER BARBARA J | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | SCHECHTER ADAM H | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | YALE PHYLLIS R | Director | Stock Award(Grant) at price 0.00 per share. | 250 | — |
| 2026-05-15 | HEARTY JAMES O | Officer | Sale at price 193.98 per share. | 15,000 | $2,909,745 |
| 2026-05-14 | HEARTY JAMES O | Officer | Conversion of Exercise of derivative security at price 110.63 per share. | 5,784 | $639,884 |
| 2026-05-12 | MAUGHAN DAVID PAUL | Officer | Sale at price 199.15 - 199.25 per share. | 20,529 | $4,089,743 |
| 2026-05-07 | ACKERMAN JOEL | Chief Financial Officer | Sale at price 192.10 per share. | 51,471 | $9,887,528 |
| 2026-05-06 | HEARTY JAMES O | Officer | Sale at price 174.87 per share. | 2,184 | $381,916 |
| 2026-05-01 | BERKSHIRE HATHAWAY, INC. | Beneficial Owner of more than 10% of a Class of Security | Sale at price 149.84 per share. | 1,220,376 | $182,864,679 |
| 2026-03-13 | ARWAY PAMELA M. | Director | Stock Award(Grant) at price 0.00 per share. | 332 | — |
| 2026-03-13 | BERRY CHRISTOPHER MICHAEL | Officer | Stock Award(Grant) at price 0.00 per share. | 3,649 | — |
| 2026-03-13 | PULLIN DENNIS W | Director | Stock Award(Grant) at price 0.00 per share. | 332 | — |
| 2026-03-13 | SCHOPPERT WENDY LEE | Director | Stock Award(Grant) at price 0.00 per share. | 332 | — |
| 2026-03-13 | MAUGHAN DAVID PAUL | Officer | Stock Award(Grant) at price 0.00 per share. | 5,308 | — |
| 2026-03-13 | HEARTY JAMES O | Officer | Stock Award(Grant) at price 0.00 per share. | 1,128 | — |
| 2026-03-13 | MOORE GREGORY J | Director | Stock Award(Grant) at price 0.00 per share. | 332 | — |
| 2026-03-13 | WATERS KATHLEEN ALYCE | Officer | Stock Award(Grant) at price 0.00 per share. | 3,185 | — |
RODRIGUEZ JAVIER J
Chief Executive Officer
Sale at price 209.28 - 209.50 per share.
2026-06-16
69,407 sh
$14,532,108
WATERS KATHLEEN ALYCE
Officer
Sale at price 207.84 - 209.17 per share.
2026-06-15
15,405 sh
$3,210,377
YALE PHYLLIS R
Director
Stock Gift at price 0.00 per share.
2026-05-26
5,038 sh
—
ARWAY PAMELA M.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
PULLIN DENNIS W
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
SCHOPPERT WENDY LEE
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
MOORE GREGORY J
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
HOLLAR JASON M
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
DESOER BARBARA J
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
SCHECHTER ADAM H
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
YALE PHYLLIS R
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-15
250 sh
—
HEARTY JAMES O
Officer
Sale at price 193.98 per share.
2026-05-15
15,000 sh
$2,909,745
HEARTY JAMES O
Officer
Conversion of Exercise of derivative security at price 110.63 per share.
2026-05-14
5,784 sh
$639,884
MAUGHAN DAVID PAUL
Officer
Sale at price 199.15 - 199.25 per share.
2026-05-12
20,529 sh
$4,089,743
ACKERMAN JOEL
Chief Financial Officer
Sale at price 192.10 per share.
2026-05-07
51,471 sh
$9,887,528
HEARTY JAMES O
Officer
Sale at price 174.87 per share.
2026-05-06
2,184 sh
$381,916
BERKSHIRE HATHAWAY, INC.
Beneficial Owner of more than 10% of a Class of Security
Sale at price 149.84 per share.
2026-05-01
1,220,376 sh
$182,864,679
ARWAY PAMELA M.
Director
Stock Award(Grant) at price 0.00 per share.
2026-03-13
332 sh
—
BERRY CHRISTOPHER MICHAEL
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-13
3,649 sh
—
PULLIN DENNIS W
Director
Stock Award(Grant) at price 0.00 per share.
2026-03-13
332 sh
—
SCHOPPERT WENDY LEE
Director
Stock Award(Grant) at price 0.00 per share.
2026-03-13
332 sh
—
MAUGHAN DAVID PAUL
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-13
5,308 sh
—
HEARTY JAMES O
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-13
1,128 sh
—
MOORE GREGORY J
Director
Stock Award(Grant) at price 0.00 per share.
2026-03-13
332 sh
—
WATERS KATHLEEN ALYCE
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-13
3,185 sh
—